eIF2A Antibodies

Santa Cruz Biotechnology delivers a wide array of eIF2A monoclonal antibodies for investigating eIF2A in cellular processes. eIF2A Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).eIF2A, or eukaryotic translation initiation factor 2A, plays a crucial role in the regulation of protein synthesis and cellular stress responses. eIF2A is involved in the initiation of translation, particularly under conditions that challenge cellular homeostasis, such as nutrient deprivation or oxidative stress. Understanding eIF2A function is essential for elucidating mechanisms of gene expression regulation and the cellular response to stress, which has implications in various diseases, including cancer and neurodegenerative disorders. Researchers can explore eIF2A's role in stress response pathways and its impact on cellular adaptation mechanisms. eIF2A research continues to reveal new insights into translation regulation and stress response pathways. Multiple detection formats are available, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of eIF2A's role in health and disease.